ReviewTranslational lung cancer research2022
Expert consensus on perioperative treatment for non-small cell lung cancer.
Abstract readReview
In one paragraph
Review in Translational lung cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Upfront surgery for clinical single-station N2 non-small cell lung cancer: real-world outcomes and implications for perioperative strategy.General thoracic and cardiovascular surgery · 2026Article
- Mediastinal staging and restaging techniques in locally advanced non-small cell lung cancer in the era of neoadjuvant and perioperative chemoimmunotherapy-a narrative review.Translational lung cancer research · 2026Review
- Bone mineral density as a prognostic marker in patients with non-small cell lung cancer undergoing neoadjuvant chemoimmunotherapy.World journal of surgical oncology · 2026Article
- A Canadian Perspective on Perioperative Systemic Therapy in Resectable Non-Small Cell Lung Cancer.Current oncology (Toronto, Ont.) · 2025Review
- Review
- Solubility, pH-Solubility Profile, pH-Rate Profile, and Kinetic Stability of the Tyrosine Kinase Inhibitor, Alectinib.Pharmaceuticals (Basel, Switzerland) · 2024Article
- Considerations for multidisciplinary management of synchronous primary breast cancer and primary lung cancer - Analysis of thirty-one patients.Thoracic cancer · 2024Article
- The quality of systematic reviews on the treatment of stage I non-small cell lung cancer for individualized decision-making: improved but further refinements are needed.Journal of thoracic disease · 2022Article
- Resectable non-small cell lung cancer: an evolving landscape.Translational lung cancer research · 2022Article
- Pharmacokinetics, tissue distribution, and antitumor activity of a novel compound, NY-2, in non-small cell lung cancer.Frontiers in pharmacology · 2022Article
Corrections and comments
- Commented on by
Authors and funding
46 authors.
Jianchun Duan *Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Fengwei Tan *Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Nan BiDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Chun ChenDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Ke-Neng ChenDepartment of Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.
Ying ChengDepartment of Medical Oncology, Jilin Cancer Hospital, Changchun, China.
Qian ChuDepartment of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Di GeDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Jie HuDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Yunchao HuangDepartment of Thoracic Surgery I, Key Laboratory of Lung Cancer of Yunnan Province, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Cancer Center of Yunnan Province, Kunming, China.
Tao JiangDepartment of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, China.
Hao LongState Key Laboratory of Oncology in Southern China, Department of Thoracic Surgery, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
You LuDepartment of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, China.
Meiqi ShiDepartment of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Jialei WangDepartment of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Qiming WangDepartment of Medical Oncology, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Fan YangDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, China.
Nong YangDepartment of Lung Cancer and Gastroenterology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Yu YaoDepartment of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jianming YingDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Caicun ZhouDepartment of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Qing ZhouGuangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Qinghua ZhouLung Cancer Institute/Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Stefano BongiolattiThoracic Surgery Unit, Careggi University Hospital, Florence, Italy.
Alessandro BrunelliDepartment of Thoracic Surgery, St. James's University Hospital, Leeds, UK.
Alfonso FiorelliThoracic Surgery Unit, Universitàdella Campania Luigi Vanvitelli, Naples, Italy.
Elisa GobbiniDepartment of Thorax, University of Grenoble, CHU Grenoble-Alpes, La Tronche, France.
Cesare GridelliDivision of Medical Oncology, "S. G. Moscati" Hospital, Avellino, Italy.
Thomas JohnDepartment of Medical Oncology, Peter MacCallum Cancer Center 305 Grattan St, Melbourne, Australia.
Jae Jun KimDepartment of Thoracic and Cardiovascular Surgery, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, College of Medicine, Seoul, Republic of Korea.
Steven H LinDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Giulio MetroMedical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy.
Fabrizio MinerviniDepartment of Thoracic Surgery, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Nuria M NovoaUniversity Hospital of Salamanca and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Dwight H OwenDivision of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Maria RodriguezDepartment of Thoracic Surgery, Clinica Universidad de Navarra, Madrid, Spain.
Ichiro SakanoueDepartment of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Marco ScarciDepartment of Cardiothoracic Surgery, Imperial College Healthcare NHS Trust, London, UK.
Kenichi SudaDivision of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Fabrizio TabbòDepartment of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy.
Terence Chi Chun TamDepartment of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Masanori TsuchidaDivision of Thoracic and Cardiovascular Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Junji UchinoDepartment of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Luca VoltoliniThoracic Surgery Unit, Careggi University Hospital, Florence, Italy.
Jie Wang *Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shugeng Gao *Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.